Eton Pharmaceuticals Inc. (ETON)
NASDAQ · Healthcare
Eton Pharmaceuticals Inc. Income Statement 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 80.0M | 39.0M | 31.6M | 21.3M | 21.8M | 39,000 | 959,000 |
| Gross Profit | 42.7M | 23.4M | 21.1M | 14.3M | 19.0M | -397,000 | 506,000 |
| Profitability | |||||||
| Operating Income | -844,000 | -2.6M | -1.2M | -8.3M | -1.5M | -27.1M | -18.6M |
| EBITDA | 3.2M | -1.5M | -291,000 | -8.2M | -1.3M | -26.8M | -18.3M |
| Net Income | -4.6M | -3.8M | -936,000 | -9.0M | -2.0M | -28.0M | -18.3M |
| Per Share Data | |||||||
| EPS (diluted) | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 27M | 27M | 26M | 25M | 25M | 24M | 18M |
Eton Pharmaceuticals Inc. Income Statement — FAQ
Eton Pharmaceuticals Inc. (ETON) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ETON's income statement history?
The chart and table above show Eton Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.